B

Brickell Biotech Inc
F:VCC2

Watchlist Manager
Brickell Biotech Inc
F:VCC2
Watchlist
Price: 0.1344 EUR 30.61% Market Closed
Market Cap: 16m EUR

Relative Value

VCC2 price has not been updated for more than 6 months. This may indicate that the stock has been delisted.
VCC2 doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of VCC2.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VCC2 Relative Value
Base Case
Not Available
B
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
2.5
Median 5Y
2.6
Industry
7.9
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-0.8
Industry
23.7
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-0.9
Industry
22
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-0.9
Industry
23.8
vs History
vs Industry
Median 3Y
2.2
Median 5Y
2.1
Industry
3.3
vs History
vs Industry
Median 3Y
1.2
Median 5Y
1.3
Industry
8.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
6.4
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
7
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.5
Industry
8.3
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.5
Industry
6.5
vs History
vs Industry
Median 3Y
13.2
Median 5Y
12
Industry
5.7

Multiples Across Competitors

VCC2 Competitors Multiples
Brickell Biotech Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Brickell Biotech Inc
F:VCC2
16m EUR 2.7 -0.9 -0.5 -0.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 786 100.8 -160 580.3 -194 995.7 -192 770.6
US
Abbvie Inc
NYSE:ABBV
398.1B USD 6.7 169.5 16.4 23.3
US
Amgen Inc
NASDAQ:AMGN
174.6B USD 4.9 24.9 18 18
US
Gilead Sciences Inc
NASDAQ:GILD
151.1B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.8B USD 9.7 31 22.7 23.7
US
Epizyme Inc
F:EPE
94.1B EUR 2 085.2 -532.1 -579.4 -563.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD 5.6 17.3 16.5 18.6
AU
CSL Ltd
ASX:CSL
84.2B AUD 3.6 18.5 12.5 15.6
NL
argenx SE
XBRU:ARGX
45B EUR 14.7 34.5 59.5 61.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.4B USD 16.3 1 203.2 158 191.7
P/E Multiple
Earnings Growth PEG
US
B
Brickell Biotech Inc
F:VCC2
Average P/E: 189.7
Negative Multiple: -0.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 580.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
169.5
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.9
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
9%
1.9
AU
CSL Ltd
ASX:CSL
18.5
11%
1.7
NL
argenx SE
XBRU:ARGX
34.5
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 203.2
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
B
Brickell Biotech Inc
F:VCC2
Average EV/EBITDA: 39.5
Negative Multiple: -0.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 995.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.4
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.7
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.4 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.5
11%
1.5
AU
CSL Ltd
ASX:CSL
12.5
8%
1.6
NL
argenx SE
XBRU:ARGX
59.5
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
158
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
B
Brickell Biotech Inc
F:VCC2
Average EV/EBIT: 45.6
Negative Multiple: -0.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 770.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.3
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.7
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.6
13%
1.4
AU
CSL Ltd
ASX:CSL
15.6
11%
1.4
NL
argenx SE
XBRU:ARGX
61.1
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
191.7
N/A N/A